For Researchers
Technology Transfer Process
F.A.Q.'s
Invention Disclosure Form
Confidentiality Agreement
Consulting Agreements
Commercial Opportunity Fund
Section J of CSU's Facility/Staff Manual
Grants
Forms
Biological Materials Invention Disclosure
Invention Disclosure
Confidentiality Agreement
Consulting Agreements
Outreach
Presentations for Download
Superclusters
Cancer Research
Clean Energy
Infectious Disease
About Us
Technology Transfer Process
Performance Statistics
Start Up Companies
In the News
Commercial Opportunity Fund
Employment
Directions to CSU Ventures
Contact Us
Agriculture
Animal Health
Biotechnology
Chemistry
Engineering
Environmental
Human Health
Information Technology
Other
Human Health
CSURF Number
Title of Technology
03-006
Anti-Androgen Effects of Equol
05-025
Evaluation of a Dynamic External Cardiac Device for the Treatment of Functional Mitral Valve Regurgitation
06-015
Repetitive Sequence-Free DNA Libraries
06-022
Menaquinone Synthesis Inhibitors as Gram-Positive Antimicrobial Drugs
06-032
Serodiagnostic Antigens for Tuberculosis
07-003
A Toll-like Receptor-2 Directed Fusion Protein Vaccine Against Tuberculosis
07-059
Deliverable RNA Aptamers that Block Late Stage of
HIV-1 Replication
07-069
A Drug-Sensitized Pseudomonas Aeruginosa Strain Useful for Drug Discovery
08-010
Asymmetrically Substituted Thiourea Derivatives: Potential Anti-TB Therapeutic Agents
08-012
Improved Diagnostic Methods for M. Tuberculosis and M. Leprae
Copyright © 2007 CSU Ventures, Inc. All rights reserved.